[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder

Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder image

Selinexor Combinations in Clinical Trials with Dr. Jeffrey Zonder

Webinar
event Feb 15, 2022 / 07:00PM - 08:00PM EST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

What kind of success have we seen when using selinexor (XPOVIO) in different combinations? What is clinical trial data telling and us and what could the future of selinexor look like? Myeloma specialist Dr. Jeffrey Zonder will join us to discuss.

Schedule & Agenda

Event panelist Audrey Burton-Bethke
07:00 PM
Introduction
Audrey Burton-Bethke
Audrey introduces the agenda of the event and featured speaker Dr. Jeffrey Zonder.
Event panelist Dr. Jeffrey Zonder
07:05 PM
Presentation
Dr. Jeffrey Zonder
Dr. Jeffrey Zonder talks about what kind of success we have seen when using selinexor (XPOVIO) in different combinations, what clinical trial data is telling us and what could the future of selinexor look like. 
Event panelist Audience
07:35 PM
Questions and Answers
Audience
Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Jeffrey Zonder, M.D.
Jeffrey Zonder, M.D.

Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and co-leader of Molecular Therapeutic Program. He is e member of the Steering Committee at the Multiple Myeloma Research Consortium, a medical advisor for the Amyloidosis Support Group Networks, and a member of the International Myeloma Working Group, the International Myeloma Society and the International Amyloidosis Society. He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis. He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York. He received his medical degree from Wayne State University School of Medicine.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.